Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 22, 2021 - Issue 10
Submit an article Journal homepage
589
Views
5
CrossRef citations to date
0
Altmetric
Review

Advances in the psychopharmacotherapy of bipolar disorder type I

Ahmad SleemMood Disorders Research Program, Depression Center Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USAView further author information
&
Rif S. El-MallakhMood Disorders Research Program, Depression Center Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USACorrespondence[email protected]
View further author information
Pages 1267-1290 | Received 07 Oct 2020, Accepted 17 Feb 2021, Published online: 26 Mar 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hagar Abuelazm, Omar H. Elsayed & Rif S. El-Mallakh. (2023) Evaluating lumateperone for its use in treating depressive episodes associated with bipolar I or II disorder in adults. Expert Review of Neurotherapeutics 23:8, pages 751-756.
Read now

Articles from other publishers (4)

Ali A. Farooqui, Jessica M. Fulkerson & Rif S. El‐Mallakh. (2023) Use of botulinum toxin A for depression symptoms in patients with treatment‐resistant bipolar illness: A case series. Bipolar Disorders.
Crossref
Gin S. Malhi, Erica Bell, Maedeh Jadidi, Michael Gitlin & Michael Bauer. (2023) Countering the declining use of lithium therapy: a call to arms. International Journal of Bipolar Disorders 11:1.
Crossref
Hiroyuki Uchida, Euitae Kim, L. Fredrik Jarskog, W. Wolfgang Fleischhacker, Gary Remington & Jeffrey A. Lieberman. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry 1 58 .
Giulio Sparacino, Norma Verdolini, Eduard Vieta & Isabella Pacchiarotti. (2022) Existing and emerging pharmacological approaches to the treatment of mania: A critical overview. Translational Psychiatry 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.